sunrise medical limited
sunrise medical limited Company Information
Company Number
03570204
Website
www.sunrisemedical.comRegistered Address
sunrise medical thorns road, brierley hill, west midlands, DY5 2LD
Industry
Other manufacturing n.e.c.
Telephone
01384421500
Next Accounts Due
March 2025
Group Structure
View All
Shareholders
sunrise medical holdings limited 100%
sunrise medical limited Estimated Valuation
Pomanda estimates the enterprise value of SUNRISE MEDICAL LIMITED at £86.9m based on a Turnover of £66.4m and 1.31x industry multiple (adjusted for size and gross margin).
sunrise medical limited Estimated Valuation
Pomanda estimates the enterprise value of SUNRISE MEDICAL LIMITED at £71.5m based on an EBITDA of £7.8m and a 9.14x industry multiple (adjusted for size and gross margin).
sunrise medical limited Estimated Valuation
Pomanda estimates the enterprise value of SUNRISE MEDICAL LIMITED at £34.4m based on Net Assets of £57m and 0.6x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sunrise Medical Limited Overview
Sunrise Medical Limited is a live company located in west midlands, DY5 2LD with a Companies House number of 03570204. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in May 1998, it's largest shareholder is sunrise medical holdings limited with a 100% stake. Sunrise Medical Limited is a mature, large sized company, Pomanda has estimated its turnover at £66.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Sunrise Medical Limited Health Check
Pomanda's financial health check has awarded Sunrise Medical Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
3 Regular
2 Weak
Size
annual sales of £66.4m, make it larger than the average company (£13.6m)
£66.4m - Sunrise Medical Limited
£13.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (4.8%)
9% - Sunrise Medical Limited
4.8% - Industry AVG
Production
with a gross margin of 28.4%, this company has a comparable cost of product (28.9%)
28.4% - Sunrise Medical Limited
28.9% - Industry AVG
Profitability
an operating margin of 9.5% make it more profitable than the average company (6.1%)
9.5% - Sunrise Medical Limited
6.1% - Industry AVG
Employees
with 209 employees, this is above the industry average (73)
209 - Sunrise Medical Limited
73 - Industry AVG
Pay Structure
on an average salary of £55.9k, the company has a higher pay structure (£40.4k)
£55.9k - Sunrise Medical Limited
£40.4k - Industry AVG
Efficiency
resulting in sales per employee of £317.5k, this is more efficient (£175.9k)
£317.5k - Sunrise Medical Limited
£175.9k - Industry AVG
Debtor Days
it gets paid by customers after 60 days, this is near the average (57 days)
60 days - Sunrise Medical Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 58 days, this is slower than average (45 days)
58 days - Sunrise Medical Limited
45 days - Industry AVG
Stock Days
it holds stock equivalent to 81 days, this is in line with average (70 days)
81 days - Sunrise Medical Limited
70 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (12 weeks)
0 weeks - Sunrise Medical Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 24.2%, this is a lower level of debt than the average (50.1%)
24.2% - Sunrise Medical Limited
50.1% - Industry AVG
SUNRISE MEDICAL LIMITED financials
Sunrise Medical Limited's latest turnover from June 2023 is £66.4 million and the company has net assets of £57 million. According to their latest financial statements, Sunrise Medical Limited has 209 employees and maintains cash reserves of £2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jul 2011 | Jul 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 66,366,000 | 55,194,000 | 47,199,000 | 50,935,000 | 52,371,000 | 50,410,000 | 41,659,000 | 37,269,000 | 33,858,000 | 32,016,000 | 28,238,000 | 28,479,000 | 28,745,000 | 33,859,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 47,490,000 | 41,426,000 | 32,323,000 | 35,180,000 | 36,139,000 | 33,472,000 | 28,629,000 | 24,898,000 | 22,897,000 | 22,166,000 | 19,041,000 | 19,236,000 | 19,841,000 | 25,257,000 |
| Gross Profit | 18,876,000 | 13,768,000 | 14,876,000 | 15,755,000 | 16,232,000 | 16,938,000 | 13,030,000 | 12,371,000 | 10,961,000 | 9,850,000 | 9,197,000 | 9,243,000 | 8,904,000 | 8,602,000 |
| Admin Expenses | 12,546,000 | 10,992,000 | 8,386,000 | 10,649,000 | 10,695,000 | 15,197,000 | 10,203,000 | 8,949,000 | 6,321,000 | 8,296,000 | 8,690,000 | 6,827,000 | 6,390,000 | 6,657,000 |
| Operating Profit | 6,330,000 | 2,776,000 | 6,490,000 | 5,106,000 | 5,537,000 | 1,741,000 | 2,827,000 | 3,422,000 | 4,640,000 | 1,554,000 | 507,000 | 2,416,000 | 2,514,000 | 1,945,000 |
| Interest Payable | 82,000 | 511,000 | 613,000 | 0 | 631,000 | 76,000 | 164,000 | 217,000 | 1,815,000 | 1,720,000 | 518,000 | 316,000 | 19,000 | 10,000 |
| Interest Receivable | 1,236,000 | 1,314,000 | 1,295,000 | 614,000 | 1,519,000 | 957,000 | 713,000 | 940,000 | 1,780,000 | 2,044,000 | 733,000 | 5,000 | 1,094,000 | 916,000 |
| Pre-Tax Profit | 8,036,000 | 5,284,000 | 7,172,000 | 5,720,000 | 6,425,000 | 2,622,000 | 3,376,000 | 4,145,000 | 4,605,000 | 1,878,000 | 1,386,000 | 2,105,000 | 3,932,000 | 2,739,000 |
| Tax | -815,000 | -287,000 | -1,008,000 | -697,000 | -344,000 | -449,000 | -399,000 | -490,000 | -1,035,000 | -595,000 | -281,000 | -700,000 | -1,184,000 | -643,000 |
| Profit After Tax | 7,221,000 | 4,997,000 | 6,164,000 | 5,023,000 | 6,081,000 | 2,173,000 | 2,977,000 | 3,655,000 | 3,570,000 | 1,283,000 | 1,105,000 | 1,405,000 | 2,748,000 | 2,096,000 |
| Dividends Paid | 0 | 0 | 0 | 7,538,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23,300,000 | 0 |
| Retained Profit | 7,221,000 | 4,997,000 | 6,164,000 | -2,515,000 | 6,081,000 | 2,173,000 | 2,977,000 | 3,655,000 | 3,570,000 | 1,283,000 | 1,105,000 | 1,405,000 | -20,552,000 | 2,096,000 |
| Employee Costs | 11,693,000 | 10,735,000 | 9,557,000 | 9,256,000 | 9,343,000 | 9,226,000 | 7,563,000 | 6,639,000 | 6,611,000 | 6,546,000 | 6,112,000 | 6,223,000 | 5,928,000 | 6,227,000 |
| Number Of Employees | 209 | 203 | 200 | 221 | 218 | 208 | 165 | 158 | 157 | 153 | 156 | 158 | 179 | 195 |
| EBITDA* | 7,817,000 | 3,960,000 | 7,973,000 | 6,612,000 | 6,975,000 | 3,094,000 | 4,085,000 | 4,365,000 | 5,240,000 | 2,073,000 | 990,000 | 2,975,000 | 3,200,000 | 2,799,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jul 2011 | Jul 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,886,000 | 1,243,000 | 876,000 | 968,000 | 1,114,000 | 979,000 | 929,000 | 1,162,000 | 786,000 | 759,000 | 619,000 | 307,000 | 413,000 | 737,000 |
| Intangible Assets | 1,498,000 | 1,997,000 | 1,841,000 | 1,400,000 | 1,943,000 | 1,981,000 | 2,813,000 | 1,159,000 | 1,209,000 | 1,385,000 | 1,522,000 | 1,848,000 | 2,174,000 | 2,500,000 |
| Investments & Other | 579,000 | 579,000 | 579,000 | 579,000 | 579,000 | 579,000 | 718,000 | 708,000 | 709,000 | 579,000 | 579,000 | 579,000 | 579,000 | 1,721,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 3,963,000 | 3,819,000 | 3,296,000 | 2,947,000 | 3,636,000 | 3,539,000 | 4,460,000 | 3,029,000 | 2,704,000 | 2,723,000 | 2,720,000 | 2,734,000 | 3,166,000 | 4,958,000 |
| Stock & work in progress | 10,638,000 | 12,453,000 | 8,909,000 | 7,993,000 | 6,118,000 | 4,404,000 | 3,459,000 | 3,388,000 | 3,577,000 | 2,556,000 | 3,159,000 | 3,478,000 | 2,978,000 | 3,175,000 |
| Trade Debtors | 10,950,000 | 9,295,000 | 6,422,000 | 3,210,000 | 6,399,000 | 6,355,000 | 5,252,000 | 5,489,000 | 3,603,000 | 3,948,000 | 3,729,000 | 3,064,000 | 3,362,000 | 3,517,000 |
| Group Debtors | 48,375,000 | 42,545,000 | 42,070,000 | 41,465,000 | 42,177,000 | 36,759,000 | 37,898,000 | 32,601,000 | 33,434,000 | 33,640,000 | 36,466,000 | 1,402,000 | 6,998,000 | 21,601,000 |
| Misc Debtors | 1,228,000 | 1,215,000 | 1,460,000 | 1,476,000 | 1,223,000 | 554,000 | 837,000 | 677,000 | 325,000 | 793,000 | 914,000 | 1,574,000 | 1,542,000 | 1,896,000 |
| Cash | 2,000 | 0 | 0 | 0 | 27,000 | 6,001,000 | 7,261,000 | 4,325,000 | 4,864,000 | 3,356,000 | 2,039,000 | 9,598,000 | 6,816,000 | 6,590,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 71,193,000 | 65,508,000 | 58,861,000 | 54,144,000 | 55,944,000 | 54,073,000 | 54,707,000 | 46,480,000 | 45,803,000 | 44,293,000 | 46,307,000 | 19,116,000 | 21,696,000 | 36,779,000 |
| total assets | 75,156,000 | 69,327,000 | 62,157,000 | 57,091,000 | 59,580,000 | 57,612,000 | 59,167,000 | 49,509,000 | 48,507,000 | 47,016,000 | 49,027,000 | 21,850,000 | 24,862,000 | 41,737,000 |
| Bank overdraft | 299,000 | 0 | 151,000 | 220,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,117,000 | 563,000 | 669,000 | 0 | 0 | 0 |
| Trade Creditors | 7,592,000 | 5,989,000 | 5,549,000 | 4,447,000 | 4,574,000 | 3,782,000 | 4,453,000 | 2,969,000 | 2,387,000 | 2,322,000 | 2,729,000 | 2,049,000 | 2,265,000 | 3,174,000 |
| Group/Directors Accounts | 2,711,000 | 7,683,000 | 6,040,000 | 7,814,000 | 7,360,000 | 12,960,000 | 24,139,000 | 18,369,000 | 7,474,000 | 9,852,000 | 10,615,000 | 7,239,000 | 8,155,000 | 4,066,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 7,433,000 | 5,723,000 | 5,449,000 | 5,986,000 | 6,507,000 | 5,803,000 | 4,685,000 | 5,258,000 | 5,271,000 | 4,706,000 | 5,619,000 | 5,251,000 | 5,418,000 | 4,921,000 |
| total current liabilities | 18,035,000 | 19,395,000 | 17,189,000 | 18,467,000 | 18,441,000 | 22,545,000 | 33,277,000 | 26,596,000 | 29,249,000 | 17,443,000 | 19,632,000 | 14,539,000 | 15,838,000 | 12,161,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,620,000 | 15,725,000 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 115,000 | 147,000 | 180,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 9,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 115,000 | 147,000 | 180,000 | 0 | 0 | 9,000 | 0 | 0 | 0 | 14,620,000 | 15,725,000 | 0 | 0 | 0 |
| total liabilities | 18,150,000 | 19,542,000 | 17,369,000 | 18,467,000 | 18,441,000 | 22,554,000 | 33,277,000 | 26,596,000 | 29,249,000 | 32,063,000 | 35,357,000 | 14,539,000 | 15,838,000 | 12,161,000 |
| net assets | 57,006,000 | 49,785,000 | 44,788,000 | 38,624,000 | 41,139,000 | 35,058,000 | 25,890,000 | 22,913,000 | 19,258,000 | 14,953,000 | 13,670,000 | 7,311,000 | 9,024,000 | 29,576,000 |
| total shareholders funds | 57,006,000 | 49,785,000 | 44,788,000 | 38,624,000 | 41,139,000 | 35,058,000 | 25,890,000 | 22,913,000 | 19,258,000 | 14,953,000 | 13,670,000 | 7,311,000 | 9,024,000 | 29,576,000 |
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jul 2011 | Jul 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 6,330,000 | 2,776,000 | 6,490,000 | 5,106,000 | 5,537,000 | 1,741,000 | 2,827,000 | 3,422,000 | 4,640,000 | 1,554,000 | 507,000 | 2,416,000 | 2,514,000 | 1,945,000 |
| Depreciation | 818,000 | 625,000 | 610,000 | 675,000 | 752,000 | 648,000 | 667,000 | 604,000 | 274,000 | 193,000 | 157,000 | 233,000 | 360,000 | 419,000 |
| Amortisation | 669,000 | 559,000 | 873,000 | 831,000 | 686,000 | 705,000 | 591,000 | 339,000 | 326,000 | 326,000 | 326,000 | 326,000 | 326,000 | 435,000 |
| Tax | -815,000 | -287,000 | -1,008,000 | -697,000 | -344,000 | -449,000 | -399,000 | -490,000 | -1,035,000 | -595,000 | -281,000 | -700,000 | -1,184,000 | -643,000 |
| Stock | -1,815,000 | 3,544,000 | 916,000 | 1,875,000 | 1,714,000 | 945,000 | 71,000 | -189,000 | 1,021,000 | -603,000 | -319,000 | 500,000 | -197,000 | 3,175,000 |
| Debtors | 7,498,000 | 3,103,000 | 3,801,000 | -3,648,000 | 6,131,000 | -319,000 | 5,220,000 | 1,405,000 | -1,019,000 | -2,728,000 | 35,069,000 | -5,862,000 | -15,112,000 | 27,014,000 |
| Creditors | 1,603,000 | 440,000 | 1,102,000 | -127,000 | 792,000 | -671,000 | 1,484,000 | 582,000 | 65,000 | -407,000 | 680,000 | -216,000 | -909,000 | 3,174,000 |
| Accruals and Deferred Income | 1,710,000 | 274,000 | -537,000 | -521,000 | 704,000 | 1,118,000 | -573,000 | -13,000 | 565,000 | -913,000 | 368,000 | -167,000 | 497,000 | 4,921,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | -9,000 | 9,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 4,632,000 | -2,260,000 | 2,813,000 | 7,040,000 | 273,000 | 2,475,000 | -694,000 | 3,228,000 | 4,833,000 | 3,489,000 | -32,993,000 | 7,254,000 | 16,913,000 | -19,938,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | -139,000 | 10,000 | -1,000 | 130,000 | 0 | 0 | 0 | -1,142,000 | 1,721,000 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,117,000 | 13,554,000 | -106,000 | 669,000 | 0 | 0 | 0 |
| Group/Directors Accounts | -4,972,000 | 1,643,000 | -1,774,000 | 454,000 | -5,600,000 | -11,179,000 | 5,770,000 | 10,895,000 | -2,378,000 | -763,000 | 3,376,000 | -916,000 | 4,089,000 | 4,066,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,620,000 | -1,105,000 | 15,725,000 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -32,000 | -33,000 | 180,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 1,154,000 | 803,000 | 682,000 | 614,000 | 888,000 | 881,000 | 549,000 | 723,000 | -35,000 | 324,000 | 215,000 | -311,000 | 1,075,000 | 906,000 |
| cash flow from financing | -3,850,000 | 2,413,000 | -912,000 | 1,068,000 | -4,712,000 | -3,303,000 | 6,319,000 | -2,499,000 | -2,744,000 | -1,650,000 | 25,239,000 | -4,345,000 | 5,164,000 | 32,452,000 |
| cash and cash equivalents | ||||||||||||||
| cash | 2,000 | 0 | 0 | -27,000 | -5,974,000 | -1,260,000 | 2,936,000 | -539,000 | 1,508,000 | 1,317,000 | -7,559,000 | 2,782,000 | 226,000 | 6,590,000 |
| overdraft | 299,000 | -151,000 | -69,000 | 220,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -297,000 | 151,000 | 69,000 | -247,000 | -5,974,000 | -1,260,000 | 2,936,000 | -539,000 | 1,508,000 | 1,317,000 | -7,559,000 | 2,782,000 | 226,000 | 6,590,000 |
sunrise medical limited Credit Report and Business Information
Sunrise Medical Limited Competitor Analysis
Perform a competitor analysis for sunrise medical limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in DY5 area or any other competitors across 12 key performance metrics.
sunrise medical limited Ownership
SUNRISE MEDICAL LIMITED group structure
Sunrise Medical Limited has 1 subsidiary company.
Ultimate parent company
CIDRON LIBERTY SYSTEMS LTD
#0100525
2 parents
SUNRISE MEDICAL LIMITED
03570204
1 subsidiary
sunrise medical limited directors
Sunrise Medical Limited currently has 4 directors. The longest serving directors include Mr Adrian Platt (Jun 2017) and Mr Bernd Krebs (Sep 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Adrian Platt | 59 years | Jun 2017 | - | Director | |
| Mr Bernd Krebs | 57 years | Sep 2017 | - | Director | |
| Mr James Barratt | 54 years | May 2018 | - | Director | |
| Mr James Barratt | England | 54 years | May 2018 | - | Director |
P&L
June 2023turnover
66.4m
+20%
operating profit
6.3m
+128%
gross margin
28.5%
+14.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
57m
+0.15%
total assets
75.2m
+0.08%
cash
2k
0%
net assets
Total assets minus all liabilities
sunrise medical limited company details
company number
03570204
Type
Private limited with Share Capital
industry
32990 - Other manufacturing n.e.c.
incorporation date
May 1998
age
26
incorporated
UK
accounts
Full Accounts
ultimate parent company
previous names
pinco 1069 limited (June 1998)
last accounts submitted
June 2023
address
sunrise medical thorns road, brierley hill, west midlands, DY5 2LD
accountant
-
auditor
MAZARS
sunrise medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to sunrise medical limited. Currently there are 1 open charges and 7 have been satisfied in the past.
sunrise medical limited Companies House Filings - See Documents
| date | description | view/download |
|---|
